Covenant Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-506
Closed -$200K 147
2025
Q2
$200K Buy
+506
New +$189K 0.06% 137
2024
Q4
Sell
-1,500
Closed -$542K 177
2024
Q3
$542K Buy
1,500
+39
+3% +$13.5K 0.16% 83
2024
Q2
$497K Hold
1,461
0.15% 95
2024
Q1
$523K Sell
1,461
-65
-4% -$21.9K 0.15% 96
2023
Q4
$457K Hold
1,526
0.14% 108
2023
Q3
$417K Sell
1,526
-62
-4% -$17.8K 0.15% 109
2023
Q2
$484K Buy
1,588
+62
+4% +$17.9K 0.18% 96
2023
Q1
$436K Hold
1,526
0.17% 101
2022
Q4
$373K Buy
1,526
+16
+1% +$3.63K 0.15% 116
2022
Q3
$306K Sell
1,510
-212
-12% -$44.6K 0.15% 126
2022
Q2
$343K Buy
+1,722
New +$404K 0.16% 122

Other funds holding SYK

Covenant Partners's SYK Position: Q3 2025 in Review

Covenant Partners sold out of Stryker (SYK) in Q3 2025, closing a stake of 506 shares — an estimated $200K sold.

Covenant Partners first reported a position in SYK in Q2 2022 and held it in 11 quarters. The position peaked at $542K in Q3 2024. 2,270 funds tracked by Wall St. Rank hold SYK as of Q3 2025.

  • Covenant Partners reported no remaining Stryker position as of Q3 2025 after selling out during the quarter.
  • Covenant Partners sold 506 Stryker shares in Q3 2025, an estimated $200K.
  • Covenant Partners first reported a position in Stryker in Q2 2022 and held it in 11 quarters.
  • Covenant Partners's Stryker position peaked at $542K in Q3 2024.
  • 2,270 funds tracked by Wall St. Rank held Stryker as of Q3 2025.

Based on Covenant Partners's 13F filing for Q3 2025, filed 24 Oct 2025.